We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News   Feb 12, 2018

 
Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Credit: Horizon

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Experimental Cell Lines Help Screening for CAR T Therapies

Product News

AMSBIO has added new experimental cell lines to its CAR T cell research range.

READ MORE

NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain

Product News

Pivotal Phase III study will further evaluate the efficacy of candidate NB-01 on pain associated with diabetic neuropathy.

READ MORE

NeuroBo Selects AiCure to Advance Pivotal Neuropathic Pain Clinical Trial

Product News

AiCure to provide AI-driven behavioral insights and improve patient compliance for NeuroBo's Phase III Diabetic Neuropathic Pain Trial.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE